{"id":1740538,"date":"2025-09-16T13:27:34","date_gmt":"2025-09-16T07:57:34","guid":{"rendered":"https:\/\/pharmint.net\/?post_type=encyclopedia&#038;p=1740538"},"modified":"2025-09-16T13:29:06","modified_gmt":"2025-09-16T07:59:06","slug":"extended-release-tablets","status":"publish","type":"encyclopedia","link":"https:\/\/pharmint.net\/ar\/glossary\/extended-release-tablets\/","title":{"rendered":"Extended\u2011Release Tablets"},"content":{"rendered":"<h3><a href=\"https:\/\/pharmint.net\/glossary\/extended-release-tablets\/\"><strong>What Are&nbsp;<\/strong><strong>Extended&#8209;Release&nbsp;<\/strong><strong>Tablets?<\/strong><\/a><\/h3>\n<p><strong>Extended&#8209;Release<\/strong><span style=\"font-weight: 400;\">&nbsp;tablets are pharmaceutical oral dosage forms designed to release the active ingredient slowly over an extended period, allowing for prolonged therapeutic effect and reducing frequency of dosing compared to immediate&#8209;release (IR) formulations.<\/span><\/p>\n<h3><strong>Why Are<\/strong>&nbsp;<strong>Extended&#8209;Release<\/strong><strong>&nbsp;Tablets Important in Pharma?<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Improve&nbsp;<\/span><strong>patient compliance<\/strong><span style=\"font-weight: 400;\">&nbsp;by reducing the number of daily doses.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Maintain more&nbsp;<\/span><strong>stable drug levels in the bloodstream<\/strong><span style=\"font-weight: 400;\">, reducing peaks and troughs and potentially fewer side effects.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Useful for chronic conditions where sustained effect is required (e.g., for pain, psychiatric, cardiovascular medications).<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Can help with market differentiation, allowing brands or suppliers on <a href=\"https:\/\/pharmint.net\/\">Pharmint<\/a> to offer forms that align with patient convenience and regulatory expectations.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>What Are the Core Principles Behind How<\/strong>&nbsp;<strong>Extended&#8209;Release&nbsp;<\/strong><strong>Tablets Work?<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><strong>Modified\/Extended&#8209;Release Technology<\/strong><span style=\"font-weight: 400;\">: Utilizing matrix systems (hydrophilic or hydrophobic), reservoir systems, osmotic systems, multiparticulate systems, etc., to control the rate of drug release.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Rate&#8209;Controlling Mechanisms<\/strong><span style=\"font-weight: 400;\">: Design of coating, diffusion, dissolution, or swelling systems that regulate how fast the drug leaves the tablet.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Drug Properties<\/strong><span style=\"font-weight: 400;\">: The active ingredient&rsquo;s solubility, half&#8209;life, dose required, stability, and first&#8209;pass metabolism influence whether the ER format is feasible.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Quality &amp; Regulatory Requirements<\/strong><span style=\"font-weight: 400;\">: Specifications include release profile (e.g., percent released at certain times), bioequivalence (for generics), stability under conditions, and safety of <a href=\"https:\/\/pharmint.net\/ar\/glossary\/excipient\/\" target=\"_self\" title=\"What is an Excipient? An&nbsp;excipient&nbsp;is an inactive substance used alongside the Active Pharmaceutical Ingredient (API) in a pharmaceutical formulation. Though excipients have no therapeutic effect, they play essential roles in drug delivery, stability, solubility, taste masking, and manufacturing processability. They are chemically stable and pharmaceutically inert but must meet stringent quality and safety standards. Why&hellip;\" class=\"encyclopedia\">excipient<\/a>s used in controlled release.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>How Do<\/strong>&nbsp;<strong>Extended&#8209;Release&nbsp;<\/strong><strong>Tablets Function in Pharma Practice?<\/strong><\/h3>\n<ol>\n<li style=\"font-weight: 400;\"><strong>Formulation Development<\/strong><span style=\"font-weight: 400;\">: Pharmaceutical scientists determine whether API and <a href=\"https:\/\/pharmint.net\/ar\/glossary\/excipient\/\" target=\"_self\" title=\"What is an Excipient? An&nbsp;excipient&nbsp;is an inactive substance used alongside the Active Pharmaceutical Ingredient (API) in a pharmaceutical formulation. Though excipients have no therapeutic effect, they play essential roles in drug delivery, stability, solubility, taste masking, and manufacturing processability. They are chemically stable and pharmaceutically inert but must meet stringent quality and safety standards. Why&hellip;\" class=\"encyclopedia\">excipient<\/a>s are suitable for extended&#8209;release (considering solubility, stability, dose).<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Selection of Release Mechanism<\/strong><span style=\"font-weight: 400;\">: Choose an appropriate system (matrix, osmotic, reservoir) depending on drug properties and desired release duration.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Manufacturing &amp; Process Control<\/strong><span style=\"font-weight: 400;\">: Manufacturing methods (compression, coating, layering) are optimized for consistent release behavior.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>In Vitro Testing for Release Profile<\/strong><span style=\"font-weight: 400;\">: Test dissolution over time in the lab to ensure the tablet releases the drug as per specification (e.g. 25% at 1 hour, 50% at 4 hr, etc.).<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Stability &amp; In Vivo Testing<\/strong><span style=\"font-weight: 400;\">: Stability under storage\/transport conditions plus often pharmacokinetic studies or bioequivalence studies to ensure desired effect in the body.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Regulatory Approval &amp; Labeling<\/strong><span style=\"font-weight: 400;\">: Documentation showing release behavior, safety, handling, possibly instructions &ldquo;do not crush\/chew&rdquo;, and dosing schedule.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ol>\n<h3><strong>Real&#8209;World Examples in Pharma Supply Chains<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">An&nbsp;<\/span><strong>Extended&#8209;Release<\/strong><span style=\"font-weight: 400;\">&nbsp;formulation of an antihypertensive medication might allow once&#8209;daily dosing instead of twice or thrice daily.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A chronic pain management drug offered as&nbsp;<\/span><strong>Extended&#8209;Release&nbsp;<\/strong><span style=\"font-weight: 400;\">tablets; avoiding frequent dosing improves compliance and reduces side effects associated with peak plasma levels.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Generic manufacturer of Pharmint ensures its&nbsp;<\/span><strong>Extended&#8209;Release<\/strong><span style=\"font-weight: 400;\">&nbsp;tablet version matches the innovator&rsquo;s bioequivalence and dissolution profile.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>Related Terms and Concepts<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Immediate&#8209;Release (IR) Tablets &ndash; the counterpart form that releases the active ingredient quickly.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Controlled&#8209;Release (CR), Sustained&#8209;Release (SR), Modified&#8209;Release &ndash; names\/acronyms used alongside ER.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Bioavailability &amp; Bioequivalence &ndash; important when comparing IR vs ER or generic ER vs innovator.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Release Profile and Dissolution Test &ndash; central parameters in ER tablets.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/glossary\/excipient\/\"><span style=\"font-weight: 400;\">Excipients&nbsp;<\/span><\/a><span style=\"font-weight: 400;\">\/ Drug Delivery Technology &ndash; polymers, coatings, or matrices used in manufacture.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h2><strong>Extended&#8209;Release<\/strong><strong>&nbsp;Tablets FAQs<\/strong><\/h2>\n<h4><strong>Are all drugs suitable for Extended&#8209;Release tablet formulation?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">No&mdash;drugs with a narrow therapeutic window, variability in absorption, high doses, or unstable in the GI tract may be unsuitable for ER formats.<\/span><\/p>\n<h4><strong>What happens if an Extended&#8209;Release tablet is crushed or chewed?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Crushing\/chewing&nbsp;<\/span><strong>Extended&#8209;Release&nbsp;<\/strong><span style=\"font-weight: 400;\">tablets destroys the release mechanism, leading to dose dumping, increased risk of toxicity, and loss of extended release property.<\/span><\/p>\n<h4><strong>How is bioequivalence demonstrated for&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release generics?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">By conducting pharmacokinetic studies comparing plasma concentration over time to the reference product, and matching dissolution profiles in vitro.<\/span><\/p>\n<h4><strong>How many times per day are&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablets typically administered?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Usually, once or twice daily, depending on how long the formulation can sustain therapeutic levels.<\/span><\/p>\n<h4><strong>What regulatory testing is required for&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablets?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Tests include in vitro dissolution over time, stability studies, in some cases human PK studies, plus compliance with GMP and pharmacopeial standards for release.<\/span><\/p>\n<h4><strong>Do&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablets reduce side effects?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">They can reduce side effects related to peak concentrations (spikes), by smoothing the release curve, but may introduce risks if misused.<\/span><\/p>\n<h4><strong>What safety instructions are common on&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablet labels?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">&ldquo;Do not crush or chew&rdquo;, clear instructions on dosing schedule, storage conditions, and sometimes warnings about altered effects in GI disorders.<\/span><\/p>\n<h4><strong>How is patient experience improved by&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablets?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Fewer doses, less fluctuation of drug levels, improved convenience&mdash;leading to better compliance and overall better therapeutic outcomes.<\/span><\/p>\n<h4><strong>How do excipients affect&nbsp;<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Extended&#8209;Release tablet performance?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/ar\/glossary\/excipient\/\" target=\"_self\" title=\"What is an Excipient? An&nbsp;excipient&nbsp;is an inactive substance used alongside the Active Pharmaceutical Ingredient (API) in a pharmaceutical formulation. Though excipients have no therapeutic effect, they play essential roles in drug delivery, stability, solubility, taste masking, and manufacturing processability. They are chemically stable and pharmaceutically inert but must meet stringent quality and safety standards. Why&hellip;\" class=\"encyclopedia\">Excipient<\/a>s (polymers, coating materials, fillers) control the release rate, protect the drug, affect stability, interact with the drug, and must be qualified and compatible.<\/span><\/p>\n","protected":false},"author":7806,"template":"","meta":{"rank_math_lock_modified_date":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ep_exclude_from_search":false},"encyclopedia-tag":[1503,1504,1502,1497,1505],"class_list":["post-1740538","encyclopedia","type-encyclopedia","status-publish","hentry","encyclopedia-tag-controlled-release-pharma","encyclopedia-tag-drug-delivery-systems","encyclopedia-tag-extended-release-tablets","encyclopedia-tag-pharma-glossary","encyclopedia-tag-sustained-release"],"_links":{"self":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia\/1740538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia"}],"about":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/types\/encyclopedia"}],"author":[{"embeddable":true,"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/users\/7806"}],"wp:attachment":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/media?parent=1740538"}],"wp:term":[{"taxonomy":"encyclopedia-tag","embeddable":true,"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia-tag?post=1740538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}